Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canóvanas, Puerto Rico
---
identifier: "/us/fr/2015-05489"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canóvanas, Puerto Rico"
title_number: 0
title_name: "Federal Register"
section_number: "2015-05489"
section_name: "Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canóvanas, Puerto Rico"
positive_law: false
currency: "2015-03-09"
last_updated: "2015-03-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2015-05489"
document_type: "notice"
publication_date: "2015-03-09"
agencies:
- "Commerce Department"
- "Foreign-Trade Zones Board"
fr_citation: "80 FR 12436"
fr_volume: 80
docket_ids:
- "B-83-2014"
---
# Foreign-Trade Zone (FTZ) 7—Mayaguez, Puerto Rico; Authorization of Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canóvanas, Puerto Rico
On November 3, 2014, the Puerto Rico Industrial Development Company, grantee of FTZ 7, submitted a notification of proposed production activity to the Foreign-Trade Zones (FTZ) Board on behalf of IPR Pharmaceuticals, Inc., located within FTZ 7, in Canóvanas, Puerto Rico.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the *Federal Register* inviting public comment (79 FR 69832, November 24, 2014). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board's regulations, including Section 400.14.
Dated: March 3, 2015.
Andrew McGilvray,
Executive Secretary.